Microphage Inc. Demonstrates Rapid Diagnostic Platform Feasibility in Skin and Soft Tissue Infections

PHILADELPHIA--(BUSINESS WIRE)--In a presentation at the current General Meeting of the American Society for Microbiology (ASM) being held in Philadelphia, PA, a simple and inexpensive developmental diagnostic assay produced by MicroPhage, Inc., www.microphage.com, was shown to be highly accurate for rapid identification of serious staph bacterial infections from skin and soft tissue infections.

MORE ON THIS TOPIC